IP Library › Assignment 052509/0608
Patent Assignment
Reel/Frame 052509/0608

Assignment of Assignor's Interest

Recorded: 2020-04-28 Pages: 6
Assignors
QIAN, WENYUAN
Executed: 2020-04-23
YANG, CHUNDAO
Executed: 2020-04-23
LI, ZHENGWEI
Executed: 2020-04-23
LI, JIE
Executed: 2020-04-23
LI, JIAN
Executed: 2020-04-23
CHEN, SHUHUI
Executed: 2020-04-23
Assignee
SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
FLOOR 16, INNOVATION BUILDING, CHANGJIANG ROAD NO.315, NEW AND HI-TECH DISTRICT, SHIJIAZHUANG, HEBEI, 050035, CHINA
Covered Property (1)
Macrocyclic Compound Serving as WEE1 Inhibitor and Applications Thereof
Application: 16/759,769 →
Publication: US 2020/0325145
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 6, 2022
From: SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
To: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
Reel/Frame 060112/0335 →